Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Endo International

Endo International reported $903.61M in Cash and Equivalent for its fiscal quarter ending in March of 2023.

Cash And Equivalent Change
Amarin AMRN:US USD 191.41M 26.25M
ANI Pharmaceuticals ANIP:US USD 67.76M 19.53M
Bristol-Myers Squibb BMY:US USD 9B 128M
Coherus Biosciences CHRS:US USD 16.14M 47.4M
Eli Lilly LLY:US USD 3.55B 1.48B
Endo International ENDP:US USD 903.61M 115.27M
Heron Therapeutics HRTX:US USD 27.09M 11.73M
Hikma Pharmaceutical HIK:LN USD 1000K 22M
Horizon Pharma HZNP:US USD 2.31B 41.2M
Ligand Pharmaceuticals LGND:US USD 282.66M 237.66M
Novartis NOVN:VX USD 12B 4.48B
Pacira PCRX:US USD 35.54M 68.59M
Patterson Companies PDCO:US USD 147.29M 7.01M
Perrigo PRGO:US USD 553M 47.7M
Phibro Animal Health PAHC:US USD 37.24M 31.18M
Revance Therapeutics RVNC:US USD 136.68M 27.71M
Supernus Pharmaceuticals SUPN:US USD 58.44M 34.68M
Takeda 4502:JP JPY 533.53B 151.61B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 2.14B 658M
Xeris Pharmaceuticals Inc XERS:US USD 50.98M 70.98M
Zoetis ZTS:US USD 2.1B 1.47B